Spots Global Cancer Trial Database for Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China
Official Title: Fat Grafting Used for the Treatment of Breast Cancer Related Lymphedema in China
Study ID: NCT02981485
Conditions
Interventions
Study Description
Brief Summary: Breast cancer related lymphedema (BRCL) is a common complication following breast cancer treatment. The incidence of BRCL ranges from 6-50%, depending on the surgical procedure in the axilla and the type of the radiation therapy. BRCL can causes cosmetic deformities, impaired physical mobility, mental discomfort, reduced quality of life and erysipelas. Therapy of BRCL is divided into conservative and operative methods. However, all the above method has some shortcomings. It is urgent to investigate new approaches to treat BRCL. In this study, fat grafting is to be used for the treatment of BRCL, and the efficacy and safety of this method will be also assessed.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Plastic Surgery Hospital of Chinese Academy of Medical Sciences, Peking Union Medical College, Shijingshan, Beijing, China
Contact Details
Name: Jie Luan, MD
Affiliation: Plastic Surgery Hospital of Chinese Academy of Medical Sciences, Peking Union Medical College
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
